Loading…
CIK 0001776382 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("venbio-partners-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALUMIS INC | COM | $13.9M | 12.1%Prev: 35.6% | 4,619,803 SH | Decreased+91,395 SH |
| ALX ONCOLOGY HLDGS INC | COM | $4.0M | 3.5%Prev: 9.2% | 9,699,925 SH | Decreased-3,184,713 SH |
| ARTIVA BIOTHERAPEUTICS INC | COM | $1.7M | 1.5%Prev: 1.2% | 1,148,975 SH | Decreased+617,638 SH |
| HARMONY BIOSCIENCES HLDGS IN | COM | $15.5M | 13.5%Prev: 4.9% | 489,194 SH | Increased |
| LYELL IMMUNOPHARMA INC | COM NEW | $4.2M | 3.6% | 473,479 SH | New |
| PHARVARIS N V | COM | $75.5M | 65.8%Prev: 46.7% | 4,289,304 SH | Decreased-350,000 SH |
| 13F-HR |
| 0000905148-26-003741 |
| $519.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000905148-25-002929 | $114.8M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000905148-26-002409 | $280.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000905148-25-001748 | $123.6M | View |